Exponent, Inc. EXPO
Nov 6, 2026, 2:02 PM EST
- YTD
- +19.63%
- 1 year
- +16.68%
- Market cap
- 3.95B
- Revenue (ttm)
- 583.12M
- Profit margin
- 19.67%
- EPS (ttm)
- 2.32
- Shares out
- 47.55M
- P/E ratio
- 35.85
- Forward P/E
- 29.95
- Dividend
- 1.24 (1.44%)
- Ex-dividend date
- Dec 3, 2026
- YTD return
- +19.63%
- 1-year return
- +16.68%
- Volume
- 169.42K
- Avg volume
- 517.07K
- Open
- 82.53
- Previous close
- 85.83
- Day's range
- 82.51 – 84.56
- 52-week range
- 51.91 – 90.51
- Beta
- 0.68
- Analysts
- Buy
- Price target
- 90.67 (+9.1%)
- Earnings date
- Feb 4, 2027
1m -3.87 (-4.45%)
Key statistics
- Enterprise value
- 4.10B
- PEG ratio
- 2.03
- Price / sales
- 7.13
- Price / book
- 13.67
- Dividend yield
- 1.44%
- Payout ratio
- 54.71%
- Revenue growth
- 11.70%
- Free cash flow
- 0
- Total cash
- 114.69M
- Total debt
- 81.14M
- Return on equity
- 32.27%
- Short % of float
- 8.06%
- 50-day average
- 70.82
- 200-day average
- 66.68
Analyst view
Consensus: buy
- Target (low)
- 82.00
- Target (mean)
- 90.67
- Target (high)
- 100.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Feb 4, 2027
Expected Feb 4, 2027. Consensus EPS estimate 0.57139.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 4, 2027 | Jan 2, 2027 | 0.53 | — | — | — |
| Oct 29, 2026 | Oct 2, 2026 | 0.596 | 0.64 | +0.04 | +7.38% |
| Jul 30, 2026 | Jul 3, 2026 | 0.549 | 0.60 | +0.05 | +9.29% |
| Apr 30, 2026 | Apr 3, 2026 | 0.56 | 0.59 | +0.03 | +5.36% |
| Feb 5, 2026 | Jan 2, 2026 | 0.47 | 0.49 | +0.02 | +4.26% |
| Oct 30, 2025 | Oct 3, 2025 | 0.50 | 0.55 | +0.05 | +10.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | UBS | main | Neutral | Neutral |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Jul 31, 2026 | UBS | main | Neutral | Neutral |
| Jul 31, 2026 | JP Morgan | main | Overweight | Overweight |
| May 15, 2026 | JP Morgan | main | Overweight | Overweight |
| May 1, 2026 | UBS | main | Neutral | Neutral |
About Exponent, Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
- Sector
- Industrials
- Industry
- Engineering & Construction
- Country
- United States
- Website
- exponent.com
News
JP Morgan Maintains Overweight on Exponent, Raises Price Target to $100
Exponent Q3 2026 Earnings Call Transcript Exponent Q3 EPS $0.64 Beats $0.60 Estimate, Sales $173.733M Beat $152.445M Estimate
Earnings Scheduled For April 30, 2026
Earnings Scheduled For February 5, 2026
Earnings Scheduled For October 30, 2025 Earnings Scheduled For July 31, 2025
Earnings Scheduled For May 1, 2025
Earnings Scheduled For February 6, 2025
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Your note
Sign in to keep a note on EXPO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN GEORGE H | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 10,730 |
| CORRIGAN CATHERINE FORD | Chief Executive Officer | Sale | Aug 16, 2026 | 129,108 |
| JOHNSTON PAUL R | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 62,940 |
| LINDSTROM CAROL J | Director | Conversion of Exercise of derivative security | Jun 2, 2026 | 9,405 |
| PYE JOHN | Officer | Conversion of Exercise of derivative security | Mar 10, 2026 | 29,131 |
| REISS RICHARD | Officer | Sale | May 18, 2026 | 2,288 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.01% | 6,184,950 | 540.75M | Jun 29, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 8.40% | 3,995,684 | 349.34M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.61% | 3,143,624 | 274.85M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.59% | 2,180,212 | 190.62M | Jun 29, 2026 |
| State Street Corporation | 4.09% | 1,943,646 | 169.93M | Jun 29, 2026 |
| Geode Capital Management, LLC | 3.68% | 1,748,031 | 152.83M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 1,691,812 | 147.92M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.24% | 1,538,230 | 134.49M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.67% | 1,270,818 | 111.11M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.33% | 1,109,114 | 96.97M | Jun 29, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 2.25% | 1,071,807 | 93.71M | Sep 29, 2026 |
| GLOBAL X FUNDS-Global X US Infrastructure Development ETF | 1.54% | 732,404 | 64.03M | Sep 29, 2026 |
